SOLUTION TO BV HOPE IT WORKS FOR YALL
Posted , 4 users are following.
I WAS WERE YOU ALL WERE ABOUT A MONTH AGO WHEN I JOINED THIS SITE AND HUNNY IVE RECENTLY WENT TO THE URGENT CARE AND I LET THE DR. KNOW THAT I KEPT HAVING THE REOCCURRENCE OF BV AND THAT IT SEEMED LIKE MY BODY BECAME IMMUNE TO THE MEDICINES I WAS BEING PRESCRIBED BECAUSE I TOOK THEM SOOO MUCH AND IT WAS GETTING ANNOYING SO I FEEL YOUR PAIN AND NONE OF THESE HOME REMEDIES WERE WORKING SO I WAS PRESCRIBED A MEDICINE ( OVULES ) THAT YOU INSERT INTO YO VAGINA AND LAY RIGHT DOWN CUZ THEY ARE DISSOLVEABLE TABLETS TO ME THEY LOOK LIKE BULLETS N E WHO THEY COME IN A DOSE OF 3 AND I ONLY HAVE INSERTED 2 OF THEM AND I HAVENT HAD ANY PROBLEMS IN LIKE 3 WEEKS EVEN AFTER MY PERIOD IM SO HAPPY NOW MY MAN CAN TASTE ME N NOT FISH LOL IM BACK N I GOT MY CONFIDENCE AGAIN AND ITS A WATER TASTE N SMELL THANK GOD I ALMOST WANTED TO GIVE UP ON SEX ALTOGETHER BUT NOW I FEEL LIKE A WOMAN AGAIN THANX TO THE ERGENT CARE DR. AT LAKESIDE URGENT CARE IN MICHIGAN OFF HALL RD.
2 likes, 9 replies
dbro9992 DATGYRL
Posted
DATGYRL dbro9992
Posted
BestHelp2 DATGYRL
Posted
DATGYRL BestHelp2
Posted
DATGYRL BestHelp2
Posted
Systemic absorption of clindamycin was estimated following a once-a-day intravaginal dose of one clindamycin phosphate vaginal suppository (equivalent to 100 mg clindamycin) administered to 11 healthy female volunteers for 3 days. Approximately 30% (range 6% to 70%) of the administered dose was absorbed systemically on day 3 of dosing based on area under the concentration-time curve (AUC). Systemic absorption was estimated using a subtherapeutic 100 mg intravenous dose of clindamycin phosphate as a comparator in the same volunteers. The mean AUC following day 3 of dosing with the suppository was 3.2 µg•hr/mL (range 0.42 to 11 µg•hr/mL). The Cmax observed on day 3 of dosing with the suppository averaged 0.27 µg/mL (range 0.03 to 0.67 µg/mL) and was observed about 5 hours after dosing (range 1 to 10 hours). In contrast, the AUC and Cmax after the single intravenous dose averaged 11 µg hr/mL (range 5.1 to 26 µg•hr/mL) and 3.7 µg/mL (range 2.4 to 5.0 µg/mL), respectively. The mean apparent elimination half-life after dosing with the suppository was 11 hours (range 4 to 35 hours) and is considered to be limited by the absorption rate.
jadene1959 DATGYRL
Posted
DATGYRL
Posted
Systemic absorption of clindamycin was estimated following a once-a-day intravaginal dose of one clindamycin phosphate vaginal suppository (equivalent to 100 mg clindamycin) administered to 11 healthy female volunteers for 3 days. Approximately 30% (range 6% to 70%) of the administered dose was absorbed systemically on day 3 of dosing based on area under the concentration-time curve (AUC). Systemic absorption was estimated using a subtherapeutic 100 mg intravenous dose of clindamycin phosphate as a comparator in the same volunteers. The mean AUC following day 3 of dosing with the suppository was 3.2 µg•hr/mL (range 0.42 to 11 µg•hr/mL). The Cmax observed on day 3 of dosing with the suppository averaged 0.27 µg/mL (range 0.03 to 0.67 µg/mL) and was observed about 5 hours after dosing (range 1 to 10 hours). In contrast, the AUC and Cmax after the single intravenous dose averaged 11 µg hr/mL (range 5.1 to 26 µg•hr/mL) and 3.7 µg/mL (range 2.4 to 5.0 µg/mL), respectively. The mean apparent elimination half-life after dosing with the suppository was 11 hours (range 4 to 35 hours) and is considered to be limited by the absorption rate.
BestHelp2 DATGYRL
Posted
DATGYRL BestHelp2
Posted